Skip to content
BritSlotsLab

Patients Stopping Weight-Loss Medications Gain Back Pounds Four Times Faster Compared to Dieters

Image of pharmaceutical syringe and scale
Weight management often requires ongoing approaches.

New research indicates that people who stop using new weight-loss injections like Wegovy and Mounjaro can put back on lost weight much more quickly than those who halt conventional diet and exercise plans.

Published data in a leading medical journal demonstrates that while obese people frequently drop about a fifth of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month once they quit.

"Users using such medications should be aware of the potential of rapid weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.

That rate of regain suggests a reversion to starting weight in about a year and a half.

Analyzing Therapies

The analysis, which looked at dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.

Researchers emphasize that individuals who shed pounds through diet and exercise typically have a more gradual weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Doctors suggest the mode of action of the drugs is key to understanding the accelerated regain.

GLP-1 drugs imitate a body's own chemical called GLP-1, which controls feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making binge eating far more likely."

A Chronic Disease?

Medical guidelines advise the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

A number of clinicians argue that, considering the likelihood of weight regain, the therapy might need to be long-term.

This opinion is supported by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," comparing it to managing diseases like high blood pressure.

Patient Experiences

People who have come off the medication describe a sudden return of cravings.

"It was like a trigger activating and you become ravenous," recalled one woman.

This difficulty is compounded if individuals have not developed permanent dietary or behavioural changes during treatment.

Widespread Adoption

Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.

  • Adoption is more common among females compared to men.
  • The 40s and 50s age group shows the highest level of interest.
  • Many obtain the medications through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent cure and long-term success likely depends on combined behavioural support.

JB
Written by

Jordan Bates

Eleanor is a seasoned casino analyst with a passion for slot machines, providing honest insights for UK gamblers.

BritSlotsLab

Type to search articles.